Retinal Disease
119
24
29
49
Key Insights
Highlights
Success Rate
78% trial completion
Published Results
17 trials with published results (14%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.8%
14 terminated out of 119 trials
77.8%
-8.7% vs benchmark
8%
10 trials in Phase 3/4
35%
17 of 49 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 49 completed trials
Clinical Trials (119)
Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene
Cell Collection to Study Eye Diseases
Collecting Data on Retinal Blood Blood Flow and Blood Vessel Shape/Appearance Using an Investigational Device, XyCAM CRE, and to Then Compare Those Images With Images Collected From a Patient's Routine Clinical Examination.
National Eye Institute Biorepository for Retinal Diseases
Establishment of a Multimodal Standard Database for Inflammation-related Ophthalmopathy
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)
A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001
Inherited Retinal Degenerative Disease Registry
COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease
Defining Retinal and Choroidal Structures Using Hyperspectral Imaging
Peripheral Retina Robotically Aligned OCT Study
Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene
Advancing Pediatric Retinal Imaging With Auto-aligned OCT
Longitudinal Observational Study of Diabetic Retinopathy Progression in Type 2 Diabetes Patients
A Multimodal AI Agent for Ophthalmic Clinical Decision Support
Data Gathering for A10900
FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD
The Genetics Navigator: Evaluating a Digital Platform for Genomics Health Services
CHOPXE - Analysis of Choriocapillaris Flow Deficits in Patients With Pseudoxanthoma Elasticum